9QD-22097-45853
3 vaccinations
3 coded responses
41 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 980 / WA
- Registered
- 2021-04-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-21
Registered in v-safe
-
2021-04-21
Dose 1 — Pfizer-BioNTech
-
2021-04-21
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-05-05
- 2021-05-12
-
2021-05-17
Dose 2 — Pfizer-BioNTech
-
2021-05-17
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-05-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Joint painsAdult check-in
- 2021-05-19
- 2021-05-20
- 2021-05-21
- 2021-05-22
- 2021-05-23
- 2021-05-24
- 2021-05-31
- 2021-06-08
- 2021-06-14
-
2021-06-21
Survey response — day 35, dose 2MedDRA: Constipation — Feeling: Fair · Be unable to do your normal daily activitiesFree text: ConstipationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-28
- 2021-08-16
-
2021-11-15
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Pregnancy +complicationsMedDRA releases: 2024-11 · check-in free text available
-
2021-11-15
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2021-11-16
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-01-08
Dose 3 — Pfizer-BioNTech
- 2022-01-08
-
2022-01-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-01-10
- 2022-01-11
- 2022-01-12
- 2022-01-13
- 2022-01-14
- 2022-01-15
- 2022-01-22
-
2022-01-29
Survey response — day 21, dose 3MedDRA: Fatigue — Feeling: FairFree text: Fatigue, feeling run downMedDRA releases: 2024-11 · check-in free text available
- 2022-02-05
- 2022-02-14
- 2022-02-21
- 2022-04-09
- 2022-07-09
- 2023-01-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-21 | Pfizer-BioNTech | |
| 2 | 2021-05-17 | Pfizer-BioNTech | |
| 3 | 2022-01-08 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 9 — day 35, dose 2
Symptoms: Constipation
Release 10 — 6 months, dose 2
Symptoms: Pregnancy +complications
Release 11 — day 21, dose 3
Symptoms: Fatigue, feeling run down
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Constipation | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release